Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Hartkopf

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Archives of Gynecology and Obstetrics|October 28, 2024
Impact of obesity on pathological complete remission in early stage breast cancer patients after neoadjuvant chemotherapy: a retrospective study from a German University breast centerJohannes Felix Englisch, Alexander Englisch, Dominik Dannehl, et al.
JMIR Research Protocols|September 22, 2021
An Activity Tracker-Guided Physical Activity Program for Patients Undergoing Radiotherapy: Protocol for a Prospective Phase III Trial (OnkoFit I and II Trials)Franziska Hauth, Barbara Gehler, Andreas Michael Nieß, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 23, 2013
Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancerTanja Fehm, Malgorzata Banys, Brigitte Rack, et al.
International Journal of Molecular Sciences|April 5, 2020
The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast CancerStefan Stefanovic, Thomas M Deutsch, Sabine Riethdorf, et al.
Cancers|September 23, 2022
Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient OutcomeFelix Ruoff, Nicolas Kersten, Nicole Anderle, et al.
Biology|December 30, 2025
Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and SurvivalAxel Gschwind, Nadja Ballin, Alexander Ott, et al.
Future Oncology (London, England)|October 24, 2024
Ovarian Cancer Retrospective European (O'CaRE) study: first-line outcomes by number of risk factors for progressionJonathan Krell, Danielle Shaw, John McGrane, et al.
Cancers|February 15, 2022
Neoadjuvant Chemotherapy of Patients with Early Breast Cancer Is Associated with Increased Detection of Disseminated Tumor Cells in the Bone MarrowLéa Volmer, André Koch, Sabine Matovina, et al.
Breast Cancer Research and Treatment|July 14, 2018
The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancerMalgorzata Banys-Paluchowski, Isabell Witzel, Sabine Riethdorf, et al.
Geburtshilfe Und Frauenheilkunde|January 16, 2026
High Adherence to Adjuvant Endocrine Therapy Improves Outcome in Early Breast Cancer - Results from a Large Real-World Claims Data Analysis in GermanyDominik Dannehl, Tjeerd Dijkstra, Lea Volmer, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Archives of Gynecology and Obstetrics|October 28, 2024
Impact of obesity on pathological complete remission in early stage breast cancer patients after neoadjuvant chemotherapy: a retrospective study from a German University breast centerJohannes Felix Englisch, Alexander Englisch, Dominik Dannehl, et al.
JMIR Research Protocols|September 22, 2021
An Activity Tracker-Guided Physical Activity Program for Patients Undergoing Radiotherapy: Protocol for a Prospective Phase III Trial (OnkoFit I and II Trials)Franziska Hauth, Barbara Gehler, Andreas Michael Nieß, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 23, 2013
Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancerTanja Fehm, Malgorzata Banys, Brigitte Rack, et al.
International Journal of Molecular Sciences|April 5, 2020
The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast CancerStefan Stefanovic, Thomas M Deutsch, Sabine Riethdorf, et al.
Cancers|September 23, 2022
Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient OutcomeFelix Ruoff, Nicolas Kersten, Nicole Anderle, et al.
Biology|December 30, 2025
Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and SurvivalAxel Gschwind, Nadja Ballin, Alexander Ott, et al.
Future Oncology (London, England)|October 24, 2024
Ovarian Cancer Retrospective European (O'CaRE) study: first-line outcomes by number of risk factors for progressionJonathan Krell, Danielle Shaw, John McGrane, et al.
Cancers|February 15, 2022
Neoadjuvant Chemotherapy of Patients with Early Breast Cancer Is Associated with Increased Detection of Disseminated Tumor Cells in the Bone MarrowLéa Volmer, André Koch, Sabine Matovina, et al.
Breast Cancer Research and Treatment|July 14, 2018
The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancerMalgorzata Banys-Paluchowski, Isabell Witzel, Sabine Riethdorf, et al.
Geburtshilfe Und Frauenheilkunde|January 16, 2026
High Adherence to Adjuvant Endocrine Therapy Improves Outcome in Early Breast Cancer - Results from a Large Real-World Claims Data Analysis in GermanyDominik Dannehl, Tjeerd Dijkstra, Lea Volmer, et al.
Pageof 9